CCR5 inhibitors: emergence, success, and challenges

Author： Maeda Kenji Das Debananda Nakata Hirotomo Mitsuya Hiroaki

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.17, Iss.2, 2012-06, pp. : 135-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CCR5 inhibitors in HIV-1 therapy

By Dorr Patrick Perros Manos

Expert Opinion on Drug Discovery, Vol. 3, Iss. 11, 2008-11 ,pp. : 1345-1361

Informa Healthcare

Access to resources Recommend Favorite

HIV Co-Receptor CCR5: Structure and Interactions with Inhibitors

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 9, Iss. 3, 2009-06 ,pp. : 279-288

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Development of Small-molecule CCR5 Inhibitors for HIV

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 13, 2010-11 ,pp. : 1277-1292

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Progress in Small Molecule CCR5 Antagonists as Potential HIV-1 Entry Inhibitors

Current Pharmaceutical Design, Vol. 18, Iss. 1, 2012-01 ,pp. : 100-112

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Progress in the Discovery of New CCR5 and CXCR4 Chemokine Receptor Antagonists as Inhibitors of HIV-1 Entry. Part 2*

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 4, Iss. 2, 2005-04 ,pp. : 133-152

Bentham Science Publishers

Access to resources Recommend Favorite